BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 21151977)

  • 1. The reverse transcription inhibitor abacavir shows anticancer activity in prostate cancer cell lines.
    Carlini F; Ridolfi B; Molinari A; Parisi C; Bozzuto G; Toccacieli L; Formisano G; De Orsi D; Paradisi S; Grober OM; Ravo M; Weisz A; Arcieri R; Vella S; Gaudi S
    PLoS One; 2010 Dec; 5(12):e14221. PubMed ID: 21151977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A tumor-promoting mechanism mediated by retrotransposon-encoded reverse transcriptase is active in human transformed cell lines.
    Sciamanna I; Gualtieri A; Cossetti C; Osimo EF; Ferracin M; Macchia G; Aricò E; Prosseda G; Vitullo P; Misteli T; Spadafora C
    Oncotarget; 2013 Dec; 4(12):2271-87. PubMed ID: 24345856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of reverse transcriptase inhibitors on LINE-1 and Ty1 reverse transcriptase activities and on LINE-1 retrotransposition.
    Dai L; Huang Q; Boeke JD
    BMC Biochem; 2011 May; 12():18. PubMed ID: 21545744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LINE-1-encoded reverse Transcriptase as a target in cancer therapy.
    Sciamanna I; Sinibaldi-Vallebona P; Serafino A; Spadafora C
    Front Biosci (Landmark Ed); 2018 Mar; 23(7):1360-1369. PubMed ID: 29293438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of LINE-1 retrotransposon-encoded reverse transcriptase modulates the expression of cell differentiation genes in breast cancer cells.
    Patnala R; Lee SH; Dahlstrom JE; Ohms S; Chen L; Dheen ST; Rangasamy D
    Breast Cancer Res Treat; 2014 Jan; 143(2):239-53. PubMed ID: 24337508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reverse transcriptase inhibitors promote the remodelling of nuclear architecture and induce autophagy in prostate cancer cells.
    Bellisai C; Sciamanna I; Rovella P; Giovannini D; Baranzini M; Pugliese GM; Zeya Ansari MS; Milite C; Sinibaldi-Vallebona P; Cirilli R; Sbardella G; Pichierri P; Trisciuoglio D; Lavia P; Serafino A; Spadafora C
    Cancer Lett; 2020 May; 478():133-145. PubMed ID: 32112906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance and cross-resistance to abacavir.
    Moyle G
    HIV Med; 2001 Jul; 2(3):154-62. PubMed ID: 11737395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abacavir induces the transcriptional activity of YY1 and other oncogenic transcription factors in gastric cancer cells.
    Panneerpandian P; Devanandan HJ; Marimuthu A; Karthikeyan C; Ganesan K
    Antiviral Res; 2020 Feb; 174():104695. PubMed ID: 31846633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the anticancer and anti-metastasis effects of novel synthetic sodium channel blockers in prostate cancer cells in vitro and in vivo.
    Wang J; Lu Z; Wu C; Li Y; Kong Y; Zhou R; Shi K; Guo J; Li N; Liu J; Song W; Wang H; Zhu M; Xu H
    Prostate; 2019 Jan; 79(1):62-72. PubMed ID: 30242862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The antiretroviral nucleoside analogue Abacavir reduces cell growth and promotes differentiation of human medulloblastoma cells.
    Rossi A; Russo G; Puca A; La Montagna R; Caputo M; Mattioli E; Lopez M; Giordano A; Pentimalli F
    Int J Cancer; 2009 Jul; 125(1):235-43. PubMed ID: 19358275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A LINE-1-encoded reverse transcriptase-dependent regulatory mechanism is active in embryogenesis and tumorigenesis.
    Spadafora C
    Ann N Y Acad Sci; 2015 Apr; 1341():164-71. PubMed ID: 25586649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene expression profiling revealed novel molecular targets of docetaxel and estramustine combination treatment in prostate cancer cells.
    Li Y; Hong X; Hussain M; Sarkar SH; Li R; Sarkar FH
    Mol Cancer Ther; 2005 Mar; 4(3):389-98. PubMed ID: 15767548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and Characterization of Specific Reverse Transcriptase Inhibitors for Mammalian LINE-1 Retrotransposons.
    Banuelos-Sanchez G; Sanchez L; Benitez-Guijarro M; Sanchez-Carnerero V; Salvador-Palomeque C; Tristan-Ramos P; Benkaddour-Boumzaouad M; Morell S; Garcia-Puche JL; Heras SR; Franco-Montalban F; Tamayo JA; Garcia-Perez JL
    Cell Chem Biol; 2019 Aug; 26(8):1095-1109.e14. PubMed ID: 31155508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiproliferative effect of 1alpha,25-dihydroxyvitamin D3 in human prostate cancer cell line LNCaP involves reduction of cyclin-dependent kinase 2 activity and persistent G1 accumulation.
    Zhuang SH; Burnstein KL
    Endocrinology; 1998 Mar; 139(3):1197-207. PubMed ID: 9492054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute and chronic resistance training downregulates select LINE-1 retrotransposon activity markers in human skeletal muscle.
    Romero MA; Mobley CB; Mumford PW; Roberson PA; Haun CT; Kephart WC; Healy JC; Beck DT; Young KC; Martin JS; Lockwood CM; Roberts MD
    Am J Physiol Cell Physiol; 2018 Mar; 314(3):C379-C388. PubMed ID: 29351416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticancer efficacy of simvastatin on prostate cancer cells and tumor xenografts is associated with inhibition of Akt and reduced prostate-specific antigen expression.
    Kochuparambil ST; Al-Husein B; Goc A; Soliman S; Somanath PR
    J Pharmacol Exp Ther; 2011 Feb; 336(2):496-505. PubMed ID: 21059805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Reverse Transcriptase Inhibitors on Proliferation, Apoptosis, and Migration in Breast Carcinoma Cells.
    Şekeroğlu ZA; Şekeroğlu V; Küçük N
    Int J Toxicol; 2021; 40(1):52-61. PubMed ID: 32975457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emodin inhibits the proliferation of PC3 prostate cancer cells in vitro via the Notch signaling pathway.
    Deng G; Ju X; Meng Q; Yu ZJ; Ma LB
    Mol Med Rep; 2015 Sep; 12(3):4427-4433. PubMed ID: 26081222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A reverse transcriptase-dependent mechanism plays central roles in fundamental biological processes.
    Spadafora C
    Syst Biol Reprod Med; 2008; 54(1):11-21. PubMed ID: 18543862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-tumor activity of non-nucleosidic reverse transcriptase inhibitors.
    Landriscina M; Spadafora C; Cignarelli M; Barone C
    Curr Pharm Des; 2007; 13(7):737-47. PubMed ID: 17346188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.